Characteristic features of actinomycin D-induced paw inflammation of the rat.
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D002199:Capillary Permeability / Q000187:drug effects; D003609:Dactinomycin / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced* / Q000188:drug therapy / Q000201:enzymology; D005070:Evans Blue / Q000378:metabolism; D005121:Extremities / Q000187:drug effects; D005966:Glucuronidase / Q000378:metabolism; D006632:Histamine / Q000378:metabolism; D006854:Hydrocortisone / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy / Q000201:enzymology; D008297:Male; D051381:Rats
D003609:Dactinomycin; D005070:Evans Blue; D006632:Histamine; D000135:Acid Phosphatase; D005966:Glucuronidase; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin